January 6: The Week in Cancer News
Cancer patients have an increased risk of breakthrough COVID-19 infections, and more of the top stories in cancer news...
Progress Against Cancer
Cancer patients have an increased risk of breakthrough COVID-19 infections, and more of the top stories in cancer news...
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...
Remote approaches would remove barriers, potentially improving patient participation and diversity.
Low- and middle-income countries make inroads against a preventable and treatable cancer.
A second KRAS inhibitor is approved for lung cancer, and a BTK inhibitor challenges standard of care for relapsed...
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
Black breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
Medical marijuana used as a substitute for opioids, and chemo and endocrine therapy together increase cancer-related cognitive impairment.
AACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.